_id
69148809ccc777a4e85d975a
Ticker
ONC
Name
BeiGene, Ltd.
Exchange
NASDAQ
Address
Aeschengraben 27, Basel, Switzerland, 4051
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://beonemedicines.com
Description
BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company's commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton's Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; and PARTRUVIX, a selective small molecule inhibitor of PARP1 and PARP2 enzymes that is being evaluated as a monotherapy and in combinations for the treatment of various solid tumors. Its clinical stage products comprise Sonrotoclax BGB-11417, a small molecule Bcl-2 inhibitor; BGB-16673, a BTK-targeting chimeric degradation activation compound active against wild-type and mutant BTK; Ociperlimab (BGB-A1217), a TIGIT inhibitor; BG-60366, an EGFR-targeted CDAC; BG-89894 (SYH2039), a MAT2A Inhibitor; BGB-58067, an MTA-Cooperative PRMT5 Inhibitor; BG-T187, an anti-EGFRxMET trispecific antibody; BGB-26808, a HPK-1 Inhibitor; BGB-C354, an anti-B7H3 ADC; Zanidatamab, a bispecific HER2-targeted antibody; BG-C137, an anti-FGFR2b ADC; BGB-53038, a Pan-KRAS Inhibitor; BGB-B2033, an anti-GPC3x4-1BB bispecific antibody; BGB-B3227, an anti-MUC1xCD16A bispecific antibody; BG-C477, an anti-CEAADC; BGB-43395, a CDK4 Inhibitor; BG-68501, a CDK2 Inhibitor; BG-C9074, an anti-B7H4 ADC; BGB-21447, a Bcl-2 Inhibitor; and BGB-45035, an IRAK4-targeted CDAC. It also has various preclinical programs. The company has agreements Amgen, BMS, Bio-Thera, EUSA Pharma, Luye Pharmaceutical, and Novartis. The company was formerly known as BeiGene, Ltd. and changed its name to BeOne Medicines AG in May 2025. BeOne Medicines AG was founded in 2010 and is based in Basel, Switzerland.
Last Close
305.32
Volume
186635
Current Price
333.99
Change
7.21
Last Updated
2026-01-05T12:10:08.121Z
Image
data:image/webp;base64,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
Ipo Date
2016-02-03T00:00:00.000Z
Market Cap
34416832512
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9511249999999999
Sentiment Sources
8
Rating
4.5833
Target Price
400.06
Strong Buy
15
Buy
8
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
1412284000
Cost Of Revenue
196510000
Gross Profit
1215774000
Operating Expenses
1052660000
Operating Income
163114000
Interest Expense
-
Pretax Income
147164000
Net Income
124841000
Eps
1.0901310590049405
Dividends Per Share
-
Shares Outstanding
101807539
Income Tax Expense
22323000
EBITDA
163114000
Operating Margin
11.549659983402771
Total Other Income Expense Net
-15950000
Cash
4036868000
Short Term Investments
-
Receivables
863281000
Inventories
531687000
Total Current Assets
5664477000
Property Plant Equipment
1768331000
Total Assets
7632586000
Payables
383676000
Short Term Debt
829028000
Long Term Debt
139571000
Total Liabilities
3503260000
Equity
4129326000
Bs_currency_symbol
USD
Depreciation
37284000
Change In Working Capital
71549000
Cash From Operations
402553000
Capital Expenditures
48084000
Cash From Investing
-49274000
Cash From Financing
961272000
Net Change In Cash
1324456000
Cf_currency_symbol
USD
PE
586.8302
PB
9.262598055813466
ROE
3.0232778908712947
ROA
1.635631750497145
FCF
354469000
Fcf Percent
0.2509898858869746
Piotroski FScore
4
Health Score
61
Deep Value Investing Score
5
Defensive Investing Score
6.5
Dividend Investing Score
3
Economic Moat Investing Score
6.3
Garp Investing Score
4.5
Growth Investing Score
5.5
Momentum Investing Score
3.5
Net Net Investing Score
2.5
Quality Investing Score
6.5
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
1412284000
Quarters > 0 > income Statement > cost Of Revenue
196510000
Quarters > 0 > income Statement > gross Profit
1215774000
Quarters > 0 > income Statement > operating Expenses
1052660000
Quarters > 0 > income Statement > operating Income
163114000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
147164000
Quarters > 0 > income Statement > net Income
124841000
Quarters > 0 > income Statement > eps
1.0901310590049405
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
114519258
Quarters > 0 > income Statement > income Tax Expense
22323000
Quarters > 0 > income Statement > EBITDA
163114000
Quarters > 0 > income Statement > operating Margin
11.549659983402771
Quarters > 0 > income Statement > total Other Income Expense Net
-15950000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
4036868000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
863281000
Quarters > 0 > balance Sheet > inventories
531687000
Quarters > 0 > balance Sheet > total Current Assets
5664477000
Quarters > 0 > balance Sheet > property Plant Equipment
1768331000
Quarters > 0 > balance Sheet > total Assets
7632586000
Quarters > 0 > balance Sheet > payables
383676000
Quarters > 0 > balance Sheet > short Term Debt
829028000
Quarters > 0 > balance Sheet > long Term Debt
139571000
Quarters > 0 > balance Sheet > total Liabilities
3503260000
Quarters > 0 > balance Sheet > equity
4129326000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
124841000
Quarters > 0 > cash Flow > depreciation
37284000
Quarters > 0 > cash Flow > change In Working Capital
71549000
Quarters > 0 > cash Flow > cash From Operations
402553000
Quarters > 0 > cash Flow > capital Expenditures
48084000
Quarters > 0 > cash Flow > cash From Investing
-49274000
Quarters > 0 > cash Flow > cash From Financing
961272000
Quarters > 0 > cash Flow > net Change In Cash
1324456000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
1.0901310590049405
Quarters > 0 > ratios > PB
9.262598055813466
Quarters > 0 > ratios > ROE
3.0232778908712947
Quarters > 0 > ratios > ROA
1.635631750497145
Quarters > 0 > ratios > FCF
354469000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.2509898858869746
Quarters > 0 > health Score
61
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
1315300000
Quarters > 1 > income Statement > cost Of Revenue
164606000
Quarters > 1 > income Statement > gross Profit
1150694000
Quarters > 1 > income Statement > operating Expenses
1062809000
Quarters > 1 > income Statement > operating Income
87885000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
99549000
Quarters > 1 > income Statement > net Income
94320000
Quarters > 1 > income Statement > eps
0.8358272049898388
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
112846291
Quarters > 1 > income Statement > income Tax Expense
5229000
Quarters > 1 > income Statement > EBITDA
123499000
Quarters > 1 > income Statement > operating Margin
6.6817456093666845
Quarters > 1 > income Statement > total Other Income Expense Net
11664000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
2756056000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
880130000
Quarters > 1 > balance Sheet > inventories
502867000
Quarters > 1 > balance Sheet > total Current Assets
4310221000
Quarters > 1 > balance Sheet > property Plant Equipment
1766408000
Quarters > 1 > balance Sheet > total Assets
6298394000
Quarters > 1 > balance Sheet > payables
360783000
Quarters > 1 > balance Sheet > short Term Debt
825644000
Quarters > 1 > balance Sheet > long Term Debt
146091000
Quarters > 1 > balance Sheet > total Liabilities
2527919000
Quarters > 1 > balance Sheet > equity
3770475000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
94320000
Quarters > 1 > cash Flow > depreciation
35614000
Quarters > 1 > cash Flow > change In Working Capital
5353000
Quarters > 1 > cash Flow > cash From Operations
263598000
Quarters > 1 > cash Flow > capital Expenditures
63826000
Quarters > 1 > cash Flow > cash From Investing
-66605000
Quarters > 1 > cash Flow > cash From Financing
35025000
Quarters > 1 > cash Flow > net Change In Cash
255495000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
0.8358272049898388
Quarters > 1 > ratios > PB
9.995964097650827
Quarters > 1 > ratios > ROE
2.501541582957054
Quarters > 1 > ratios > ROA
1.4975246070664998
Quarters > 1 > ratios > FCF
199772000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.1518832205580476
Quarters > 1 > health Score
56
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
1117279000
Quarters > 2 > income Statement > cost Of Revenue
165002000
Quarters > 2 > income Statement > gross Profit
952277000
Quarters > 2 > income Statement > operating Expenses
941175000
Quarters > 2 > income Statement > operating Income
11102000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
20900000
Quarters > 2 > income Statement > net Income
1270000
Quarters > 2 > income Statement > eps
0.011423603638732583
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
111173325
Quarters > 2 > income Statement > income Tax Expense
19630000
Quarters > 2 > income Statement > EBITDA
43906000
Quarters > 2 > income Statement > operating Margin
0.9936640713733992
Quarters > 2 > income Statement > total Other Income Expense Net
9798000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
2516411000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
745977000
Quarters > 2 > balance Sheet > inventories
494660000
Quarters > 2 > balance Sheet > total Current Assets
3896492000
Quarters > 2 > balance Sheet > property Plant Equipment
1760669000
Quarters > 2 > balance Sheet > total Assets
5841526000
Quarters > 2 > balance Sheet > payables
364498000
Quarters > 2 > balance Sheet > short Term Debt
781773000
Quarters > 2 > balance Sheet > long Term Debt
160157000
Quarters > 2 > balance Sheet > total Liabilities
2342013000
Quarters > 2 > balance Sheet > equity
3499513000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
1270000
Quarters > 2 > cash Flow > depreciation
32804000
Quarters > 2 > cash Flow > change In Working Capital
-78027000
Quarters > 2 > cash Flow > cash From Operations
44082000
Quarters > 2 > cash Flow > capital Expenditures
116407000
Quarters > 2 > cash Flow > cash From Investing
-121941000
Quarters > 2 > cash Flow > cash From Financing
-33777000
Quarters > 2 > cash Flow > net Change In Cash
-108156000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
0.011423603638732583
Quarters > 2 > ratios > PB
10.6102702909662
Quarters > 2 > ratios > ROE
0.036290763886289316
Quarters > 2 > ratios > ROA
0.02174089441697255
Quarters > 2 > ratios > FCF
-72325000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
-0.06473315975687362
Quarters > 2 > health Score
39
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
1127824000
Quarters > 3 > income Statement > cost Of Revenue
160560000
Quarters > 3 > income Statement > gross Profit
967264000
Quarters > 3 > income Statement > operating Expenses
1046689000
Quarters > 3 > income Statement > operating Income
-79425000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-85351000
Quarters > 3 > income Statement > net Income
-151881000
Quarters > 3 > income Statement > eps
-1.4293337097684924
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
106260000
Quarters > 3 > income Statement > income Tax Expense
66530000
Quarters > 3 > income Statement > EBITDA
-29179000
Quarters > 3 > income Statement > operating Margin
-7.042322206301692
Quarters > 3 > income Statement > total Other Income Expense Net
-5926000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
2627410000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
709106000
Quarters > 3 > balance Sheet > inventories
494986000
Quarters > 3 > balance Sheet > total Current Assets
3991593000
Quarters > 3 > balance Sheet > property Plant Equipment
1657238000
Quarters > 3 > balance Sheet > total Assets
5920910000
Quarters > 3 > balance Sheet > payables
404997000
Quarters > 3 > balance Sheet > short Term Debt
869105000
Quarters > 3 > balance Sheet > long Term Debt
166484000
Quarters > 3 > balance Sheet > total Liabilities
2588688000
Quarters > 3 > balance Sheet > equity
3332222000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-151881000
Quarters > 3 > cash Flow > depreciation
50246000
Quarters > 3 > cash Flow > change In Working Capital
-18862000
Quarters > 3 > cash Flow > cash From Operations
75160000
Quarters > 3 > cash Flow > capital Expenditures
92480000
Quarters > 3 > cash Flow > cash From Investing
-93605000
Quarters > 3 > cash Flow > cash From Financing
-4523000
Quarters > 3 > cash Flow > net Change In Cash
-74681000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-1.4293337097684924
Quarters > 3 > ratios > PB
10.650484091396072
Quarters > 3 > ratios > ROE
-4.557949620403442
Quarters > 3 > ratios > ROA
-2.5651631252628393
Quarters > 3 > ratios > FCF
-17320000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-0.015357006057682759
Quarters > 3 > health Score
24
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
3810241000
Annuals > 0 > income Statement > cost Of Revenue
594089000
Annuals > 0 > income Statement > gross Profit
3216152000
Annuals > 0 > income Statement > operating Expenses
3784351000
Annuals > 0 > income Statement > operating Income
-568199000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-533001000
Annuals > 0 > income Statement > net Income
-644786000
Annuals > 0 > income Statement > eps
-6.124021730871514
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
105288000
Annuals > 0 > income Statement > income Tax Expense
111785000
Annuals > 0 > income Statement > EBITDA
-396437000
Annuals > 0 > income Statement > operating Margin
-14.91241630122609
Annuals > 0 > income Statement > total Other Income Expense Net
35198000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
2627410000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
709106000
Annuals > 0 > balance Sheet > inventories
494986000
Annuals > 0 > balance Sheet > total Current Assets
3991593000
Annuals > 0 > balance Sheet > property Plant Equipment
1657238000
Annuals > 0 > balance Sheet > total Assets
5920910000
Annuals > 0 > balance Sheet > payables
404997000
Annuals > 0 > balance Sheet > short Term Debt
869105000
Annuals > 0 > balance Sheet > long Term Debt
166484000
Annuals > 0 > balance Sheet > total Liabilities
2588688000
Annuals > 0 > balance Sheet > equity
3332222000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-644786000
Annuals > 0 > cash Flow > depreciation
171762000
Annuals > 0 > cash Flow > change In Working Capital
-157167000
Annuals > 0 > cash Flow > cash From Operations
-140631000
Annuals > 0 > cash Flow > capital Expenditures
529137000
Annuals > 0 > cash Flow > cash From Investing
-548350000
Annuals > 0 > cash Flow > cash From Financing
193449000
Annuals > 0 > cash Flow > net Change In Cash
-547237000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-6.124021730871514
Annuals > 0 > ratios > PB
9.827278542666125
Annuals > 0 > ratios > ROE
-19.350031300435568
Annuals > 0 > ratios > ROA
-10.88998143866399
Annuals > 0 > ratios > FCF
-669768000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.17578100702816435
Annuals > 0 > health Score
22
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
2458779000
Annuals > 1 > income Statement > cost Of Revenue
379920000
Annuals > 1 > income Statement > gross Profit
2078859000
Annuals > 1 > income Statement > operating Expenses
3286595000
Annuals > 1 > income Statement > operating Income
-1207736000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-825836000
Annuals > 1 > income Statement > net Income
-881708000
Annuals > 1 > income Statement > eps
-8.446508689296909
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
104387272
Annuals > 1 > income Statement > income Tax Expense
55872000
Annuals > 1 > income Statement > EBITDA
-1120061000
Annuals > 1 > income Statement > operating Margin
-49.11933931435074
Annuals > 1 > income Statement > total Other Income Expense Net
381900000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
3171800000
Annuals > 1 > balance Sheet > short Term Investments
2600000
Annuals > 1 > balance Sheet > receivables
395886000
Annuals > 1 > balance Sheet > inventories
416122000
Annuals > 1 > balance Sheet > total Current Assets
4203414000
Annuals > 1 > balance Sheet > property Plant Equipment
1371788000
Annuals > 1 > balance Sheet > total Assets
5805275000
Annuals > 1 > balance Sheet > payables
315111000
Annuals > 1 > balance Sheet > short Term Debt
710316000
Annuals > 1 > balance Sheet > long Term Debt
197618000
Annuals > 1 > balance Sheet > total Liabilities
2267948000
Annuals > 1 > balance Sheet > equity
3537327000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-881708000
Annuals > 1 > cash Flow > depreciation
87675000
Annuals > 1 > cash Flow > change In Working Capital
-370539000
Annuals > 1 > cash Flow > cash From Operations
-1157453000
Annuals > 1 > cash Flow > capital Expenditures
596261000
Annuals > 1 > cash Flow > cash From Investing
60004000
Annuals > 1 > cash Flow > cash From Financing
416478000
Annuals > 1 > cash Flow > net Change In Cash
-689053000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-8.446508689296909
Annuals > 1 > ratios > PB
9.178266339934078
Annuals > 1 > ratios > ROE
-24.925826761280483
Annuals > 1 > ratios > ROA
-15.188048800444424
Annuals > 1 > ratios > FCF
-1753714000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.7132458834242524
Annuals > 1 > health Score
22
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1415921000
Annuals > 2 > income Statement > cost Of Revenue
286475000
Annuals > 2 > income Statement > gross Profit
1129446000
Annuals > 2 > income Statement > operating Expenses
2919111000
Annuals > 2 > income Statement > operating Income
-1789665000
Annuals > 2 > income Statement > interest Expense
52480000
Annuals > 2 > income Statement > pretax Income
-1961037000
Annuals > 2 > income Statement > net Income
-2003815000
Annuals > 2 > income Statement > eps
-19.429417791643967
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
103133044
Annuals > 2 > income Statement > income Tax Expense
42778000
Annuals > 2 > income Statement > EBITDA
-1723387000
Annuals > 2 > income Statement > operating Margin
-126.3958229307991
Annuals > 2 > income Statement > total Other Income Expense Net
-171372000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
3869564000
Annuals > 2 > balance Sheet > short Term Investments
665251000
Annuals > 2 > balance Sheet > receivables
198984000
Annuals > 2 > balance Sheet > inventories
282346000
Annuals > 2 > balance Sheet > total Current Assets
5207078000
Annuals > 2 > balance Sheet > property Plant Equipment
923979000
Annuals > 2 > balance Sheet > total Assets
6379290000
Annuals > 2 > balance Sheet > payables
294781000
Annuals > 2 > balance Sheet > short Term Debt
353010000
Annuals > 2 > balance Sheet > long Term Debt
209148000
Annuals > 2 > balance Sheet > total Liabilities
1995935000
Annuals > 2 > balance Sheet > equity
4383355000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-2003815000
Annuals > 2 > cash Flow > depreciation
66278000
Annuals > 2 > cash Flow > change In Working Capital
132391000
Annuals > 2 > cash Flow > cash From Operations
-1496619000
Annuals > 2 > cash Flow > capital Expenditures
469099000
Annuals > 2 > cash Flow > cash From Investing
1077123000
Annuals > 2 > cash Flow > cash From Financing
-18971000
Annuals > 2 > cash Flow > net Change In Cash
-507850000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-19.429417791643967
Annuals > 2 > ratios > PB
7.3177826904003895
Annuals > 2 > ratios > ROE
-45.714184682737304
Annuals > 2 > ratios > ROA
-31.411254230486463
Annuals > 2 > ratios > FCF
-1965718000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-1.3882963809421571
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
1176283000
Annuals > 3 > income Statement > cost Of Revenue
164906000
Annuals > 3 > income Statement > gross Profit
1011377000
Annuals > 3 > income Statement > operating Expenses
2450112000
Annuals > 3 > income Statement > operating Income
-1438735000
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-1438588000
Annuals > 3 > income Statement > net Income
-1457816000
Annuals > 3 > income Statement > eps
-15.71169805314604
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
92785388
Annuals > 3 > income Statement > income Tax Expense
19228000
Annuals > 3 > income Statement > EBITDA
-1392278000
Annuals > 3 > income Statement > operating Margin
-122.31197764483548
Annuals > 3 > income Statement > total Other Income Expense Net
147000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
4375678000
Annuals > 3 > balance Sheet > short Term Investments
2241962000
Annuals > 3 > balance Sheet > receivables
500175000
Annuals > 3 > balance Sheet > inventories
242626000
Annuals > 3 > balance Sheet > total Current Assets
7613880000
Annuals > 3 > balance Sheet > property Plant Equipment
662507000
Annuals > 3 > balance Sheet > total Assets
8535525000
Annuals > 3 > balance Sheet > payables
262400000
Annuals > 3 > balance Sheet > short Term Debt
449490000
Annuals > 3 > balance Sheet > long Term Debt
202113000
Annuals > 3 > balance Sheet > total Liabilities
2402962000
Annuals > 3 > balance Sheet > equity
6132563000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-1413354000
Annuals > 3 > cash Flow > depreciation
46457000
Annuals > 3 > cash Flow > change In Working Capital
-118345000
Annuals > 3 > cash Flow > cash From Operations
-1298723000
Annuals > 3 > cash Flow > capital Expenditures
314851000
Annuals > 3 > cash Flow > cash From Investing
640659000
Annuals > 3 > cash Flow > cash From Financing
3636911000
Annuals > 3 > cash Flow > net Change In Cash
2992882000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-15.71169805314604
Annuals > 3 > ratios > PB
4.705717882679721
Annuals > 3 > ratios > ROE
-23.77172480739293
Annuals > 3 > ratios > ROA
-17.079394647663733
Annuals > 3 > ratios > FCF
-1613574000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-1.3717566265941104
Annuals > 3 > health Score
29
Valuation > metrics > PE
586.8302
Valuation > metrics > PB
9.262598055813466
Valuation > final Score
1
Valuation > verdict
1228.0% Overvalued
Profitability > metrics > ROE
3.0232778908712947
Profitability > metrics > ROA
2.203928094332451
Profitability > metrics > Net Margin
0.08839652647767729
Profitability > final Score
26
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.8483854265805122
Risk > metrics > Interest Coverage
10.226583072100313
Risk > final Score
88
Risk > verdict
Low
Liquidity > metrics > Current Ratio
4.670947733329815
Liquidity > metrics > Quick Ratio
4.232516755943743
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
40
Prev Valuations > 1
40
Prev Valuations > 2
20
Prev Profitabilities > 0
22
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
63
Prev Risks > 1
50
Prev Risks > 2
42
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:20:44.224Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-04-01
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
1.41
Earnings History > 0 > eps Difference
-1.41
Earnings History > 0 > surprise Percent
-100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-06
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
2.65
Earnings History > 1 > eps Estimate
0.8
Earnings History > 1 > eps Difference
1.85
Earnings History > 1 > surprise Percent
231.25
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-06
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.78
Earnings History > 2 > eps Estimate
0.21
Earnings History > 2 > eps Difference
0.57
Earnings History > 2 > surprise Percent
271.4286
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-07
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0.01
Earnings History > 3 > eps Estimate
-0.43
Earnings History > 3 > eps Difference
0.44
Earnings History > 3 > surprise Percent
102.3256
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-27
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-1.43
Earnings History > 4 > eps Estimate
-1.01
Earnings History > 4 > eps Difference
-0.42
Earnings History > 4 > surprise Percent
-41.5842
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-12
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-0.09
Earnings History > 5 > eps Estimate
-1.04
Earnings History > 5 > eps Difference
0.95
Earnings History > 5 > surprise Percent
91.3462
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-07
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-1.15
Earnings History > 6 > eps Estimate
-2.19
Earnings History > 6 > eps Difference
1.04
Earnings History > 6 > surprise Percent
47.4886
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-08
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-2.41
Earnings History > 7 > eps Estimate
-2.92
Earnings History > 7 > eps Difference
0.51
Earnings History > 7 > surprise Percent
17.4658
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-02-26
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
-3.53
Earnings History > 8 > eps Estimate
-3.54
Earnings History > 8 > eps Difference
0.01
Earnings History > 8 > surprise Percent
0.2825
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-09
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
2.01
Earnings History > 9 > eps Estimate
2.01
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
0
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-02
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
-0.28
Earnings History > 10 > eps Estimate
-3.37
Earnings History > 10 > eps Difference
3.09
Earnings History > 10 > surprise Percent
91.6914
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-04
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
-3.34
Earnings History > 11 > eps Estimate
-3.34
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
0
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-02-27
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-4.29
Earnings History > 12 > eps Estimate
-4.35
Earnings History > 12 > eps Difference
0.06
Earnings History > 12 > surprise Percent
1.3793
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-09
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-5.39
Earnings History > 13 > eps Estimate
-5.39
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
0
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-04
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
-5.56
Earnings History > 14 > eps Estimate
-5.56
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
0
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-05
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
-4.24
Earnings History > 15 > eps Estimate
-4.24
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
0
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-02-25
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
-6.16
Earnings History > 16 > eps Estimate
-6.16
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
0
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-04
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
-
Earnings History > 17 > eps Actual
-4.46
Earnings History > 17 > eps Estimate
-4.46
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
0
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-05
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
-
Earnings History > 18 > eps Actual
-5.23
Earnings History > 18 > eps Estimate
-5.23
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
0
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-06
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
-
Earnings History > 19 > eps Actual
0.69
Earnings History > 19 > eps Estimate
0.69
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
0
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-02-25
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
-
Earnings History > 20 > eps Actual
-5.2
Earnings History > 20 > eps Estimate
-5.2
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
0
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-05
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
-
Earnings History > 21 > eps Actual
-4.81
Earnings History > 21 > eps Estimate
-4.81
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
0
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-08-06
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
-
Earnings History > 22 > eps Actual
-4.31
Earnings History > 22 > eps Estimate
-4.31
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
0
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-05-11
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
-
Earnings History > 23 > eps Actual
-4.7
Earnings History > 23 > eps Estimate
-4.7
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
0
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-03-02
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
-
Earnings History > 24 > eps Actual
-6.3279
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-11-13
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
-
Earnings History > 25 > eps Actual
-5.1129
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-08-09
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
-
Earnings History > 26 > eps Actual
-1.4307
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-05-10
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
-
Earnings History > 27 > eps Actual
-2.8129
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-12-31
Earnings History > 28 > report Date
2019-02-27
Earnings History > 28 > date
2018-12-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
-
Earnings History > 28 > eps Actual
-4.4857
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-09-30
Earnings History > 29 > report Date
2018-11-07
Earnings History > 29 > date
2018-09-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
-
Earnings History > 29 > eps Actual
-2.4121
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2018-06-30
Earnings History > 30 > report Date
2018-08-30
Earnings History > 30 > date
2018-06-30
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
-
Earnings History > 30 > eps Actual
-2.6274
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2018-03-31
Earnings History > 31 > report Date
2018-05-10
Earnings History > 31 > date
2018-03-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
-
Earnings History > 31 > eps Actual
-1.7517
Earnings History > 31 > eps Estimate
-
Earnings History > 31 > eps Difference
0
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2017-12-31
Earnings History > 32 > report Date
2018-03-01
Earnings History > 32 > date
2017-12-31
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
-
Earnings History > 32 > eps Actual
-1.6712
Earnings History > 32 > eps Estimate
-
Earnings History > 32 > eps Difference
0
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2017-09-30
Earnings History > 33 > report Date
2017-11-14
Earnings History > 33 > date
2017-09-30
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
-
Earnings History > 33 > eps Actual
1.9659
Earnings History > 33 > eps Estimate
-
Earnings History > 33 > eps Difference
0
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2017-06-30
Earnings History > 34 > report Date
2017-08-10
Earnings History > 34 > date
2017-06-30
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
-
Earnings History > 34 > eps Actual
-1.0139
Earnings History > 34 > eps Estimate
-
Earnings History > 34 > eps Difference
0
Earnings History > 34 > surprise Percent
-
Earnings History > 35 > period
2017-03-31
Earnings History > 35 > report Date
2017-05-11
Earnings History > 35 > date
2017-03-31
Earnings History > 35 > before After Market
-
Earnings History > 35 > currency
-
Earnings History > 35 > eps Actual
-0.8478
Earnings History > 35 > eps Estimate
-
Earnings History > 35 > eps Difference
0
Earnings History > 35 > surprise Percent
-
Earnings History > 36 > period
2016-12-31
Earnings History > 36 > report Date
2017-03-23
Earnings History > 36 > date
2016-12-31
Earnings History > 36 > before After Market
-
Earnings History > 36 > currency
-
Earnings History > 36 > eps Actual
-0.6262
Earnings History > 36 > eps Estimate
-
Earnings History > 36 > eps Difference
0
Earnings History > 36 > surprise Percent
-
Earnings History > 37 > period
2016-09-30
Earnings History > 37 > report Date
2016-11-10
Earnings History > 37 > date
2016-09-30
Earnings History > 37 > before After Market
-
Earnings History > 37 > currency
-
Earnings History > 37 > eps Actual
-0.5944
Earnings History > 37 > eps Estimate
-
Earnings History > 37 > eps Difference
0
Earnings History > 37 > surprise Percent
-
Earnings History > 38 > period
2016-06-30
Earnings History > 38 > report Date
2016-08-11
Earnings History > 38 > date
2016-06-30
Earnings History > 38 > before After Market
-
Earnings History > 38 > currency
-
Earnings History > 38 > eps Actual
-0.404
Earnings History > 38 > eps Estimate
-
Earnings History > 38 > eps Difference
0
Earnings History > 38 > surprise Percent
-
Earnings History > 39 > period
2016-03-31
Earnings History > 39 > report Date
2016-05-12
Earnings History > 39 > date
2016-03-31
Earnings History > 39 > before After Market
-
Earnings History > 39 > currency
-
Earnings History > 39 > eps Actual
-0.3684
Earnings History > 39 > eps Estimate
-
Earnings History > 39 > eps Difference
0
Earnings History > 39 > surprise Percent
-
BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company's commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton's Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; and PARTRUVIX, a selective small molecule inhibitor of PARP1 and PARP2 enzymes that is being evaluated as a monotherapy and in combinations for the treatment of various solid tumors. Its clinical stage products comprise Sonrotoclax BGB-11417, a small molecule Bcl-2 inhibitor; BGB-16673, a BTK-targeting chimeric degradation activation compound active against wild-type and mutant BTK; Ociperlimab (BGB-A1217), a TIGIT inhibitor; BG-60366, an EGFR-targeted CDAC; BG-89894 (SYH2039), a MAT2A Inhibitor; BGB-58067, an MTA-Cooperative PRMT5 Inhibitor; BG-T187, an anti-EGFRxMET trispecific antibody; BGB-26808, a HPK-1 Inhibitor; BGB-C354, an anti-B7H3 ADC; Zanidatamab, a bispecific HER2-targeted antibody; BG-C137, an anti-FGFR2b ADC; BGB-53038, a Pan-KRAS Inhibitor; BGB-B2033, an anti-GPC3x4-1BB bispecific antibody; BGB-B3227, an anti-MUC1xCD16A bispecific antibody; BG-C477, an anti-CEAADC; BGB-43395, a CDK4 Inhibitor; BG-68501, a CDK2 Inhibitor; BG-C9074, an anti-B7H4 ADC; BGB-21447, a Bcl-2 Inhibitor; and BGB-45035, an IRAK4-targeted CDAC. It also has various preclinical programs. The company has agreements Amgen, BMS, Bio-Thera, EUSA Pharma, Luye Pharmaceutical, and Novartis. The company was formerly known as BeiGene, Ltd. and changed its name to BeOne Medicines AG in May 2025. BeOne Medicines AG was founded in 2010 and is based in Basel, Switzerland.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ABEONE MEDICINES LTD-ADR (NASDAQ:ONC) Passes Minervini Trend Template and Strong Growth Scan Chartmill
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$400.06
Analyst Picks
Strong Buy
15
Buy
8
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very Low
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of BeiGene, Ltd.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
1.41
Date
2025-09-30
EPS Actual
2.65
EPS Estimate
0.8
EPS Difference
1.85
Surprise Percent
231.25%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.